8-K current report · filed Nov 13, 2026

aTYR PHARMA INC (ATYR) 8-K Current Report: November 13, 2026

Item 8.01ATYR overview

Short answer

aTYR PHARMA INC (ATYR) filed an 8-K current report with the SEC on November 13, 2026 reporting Item 8.01 (Other Events). Nasdaq minimum bid-price compliance restored after shares closed at least $1.00 for 10 consecutive business days.

aTYR PHARMA INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 8.01 · Other Events

  • Nasdaq minimum bid-price compliance restored after shares closed at least $1.00 for 10 consecutive business days
  • Compliance period ran October 30 through November 12, 2026
  • Delisting risk from Nasdaq Listing Rule 5550(a)(2) removed, with no outstanding Nasdaq deficiency notices
  • Prior 180-day extension would have expired November 30, 2026

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other aTYR PHARMA INC 8-K filings

Get the next ATYR 8-K as it lands

Follow ATYR for push alerts, or ask the research agent what this filing means.